AnaptysBio Inc.

NASDAQ: ANAB · Real-Time Price · USD
20.11
0.14 (0.70%)
At close: Aug 15, 2025, 3:59 PM
20.14
0.12%
After-hours: Aug 15, 2025, 04:10 PM EDT

AnaptysBio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-145.23M -163.62M -128.72M -57.8M
Depreciation & Amortization
2.4M 2.38M 2.33M 2.09M
Stock-Based Compensation
34.05M 33.2M 27.36M 15.35M
Other Working Capital
1.43M -11.26M -2.32M -1.87M
Other Non-Cash Items
39.77M 7.56M 18.6M 1.45M
Deferred Income Tax
n/a n/a n/a 478K
Change in Working Capital
-66.33M -324K 6.84M -7.49M
Operating Cash Flow
-135.34M -120.8M -73.59M -45.92M
Capital Expenditures
-358K -807K -358K -1.37M
Cash Acquisitions
n/a n/a 394.49M 15K
Purchase of Investments
-380.38M -303.92M -802.5M -118.66M
Sales Maturities Of Investments
476.13M 449.48M 408.02M 158.85M
Other Investing Acitivies
n/a n/a -394.49M 40.2M
Investing Cash Flow
95.4M 144.75M -394.85M 38.84M
Debt Repayment
n/a -11.73M n/a n/a
Common Stock Repurchased
-456K -50M n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
26.67M -43K 32.19M 249.75M
Financial Cash Flow
127.05M -59.3M 44.02M 252.3M
Net Cash Flow
87.11M -35.34M -424.42M 245.21M
Free Cash Flow
-135.69M -121.61M -73.95M -47.29M